Lifelong viral infections can quietly alter the immune system, with effects that persist over the time. Viruses such as the ...
The field of bacteriophage research is rapidly evolving, offering new perspectives on the complex interplay between phages, bacteria, and host immune ...
Researchers uncover that ALV-J boosts miR-155 to suppress TRAF3 and STAT1, weakening immune responses and promoting viral ...
Two therapies can be better than one for treating some cancers, concludes a Yale study published Oct. 22 in JCI Insight that ...
The preclinical drug from Vanqua Bio is designed to inhibit “C5aR1,” a part of the immune system that regulates inflammation.
Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.
The oral C5aR1 antagonist is designed to modulate neutrophil-driven inflammation, a central mechanism underlying many inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback